PCSK9 Forum
Click here to forward this email to a colleague
Facebook Twitter RSS YouTube linkedin
Home  |  About  |  PCSK9  |  News  |  Commentary  |  Trials  |  Videos  |  Resources  |  Contact
News from 2019 European Society of Cardiology Congress, 31 August – 4 September, 2019

More than 32,000 delegates from over 150 countries are attending this year’s Congress held in Paris, France. The critical importance of this meeting is underlined by recent news that cardiovascular disease mortality is now increasing in Europe, for the first time in 50 years. Global cardiovascular health is therefore an urgent priority.

Leading the news from the Congress was the release of five new guidelines from the Society, including guidelines for the management of dyslipidaemia and diabetes. LDL cholesterol is the indisputable primary lipid target; the Joint European Society of Cardiology/European Atherosclerosis Society Task Force have taken account of the clinical trials evidence and lowered LDL cholesterol goals in high and very high-risk patients.

Read the summary »

Erik

Watch a perspective from PCSK9 Forum Editor, Professor John Chapman

Watch it here »


In the poster sessions there was also important news.


Jan

Professor Kausik Ray (Imperial College, London, UK) presented date for the real-world use of evolocumab in familial hypercholesterolaemia in Europe.

Read the report and watch the video »



Ference

Professor Gregory Schwartz (University of Colorado School of Medicine, Aurora, Colorado, USA) discussed data from ODYSSEY OUTCOMES regarding the efficacy and safety of very low LDL cholesterol levels.

Read the report and watch the video »

Check back for more news from ESC Congress 2019.


Don't miss our slide decks focusing on key results and expert analysis from FOURIER and ODYSSEY OUTCOMES


DOWNLOAD THEM NOW »

Register now at www.pcsk9forum.org to access our new slide deck programme.
PCSK9 App


Education: the primary mission of PCSK9 Forum.

Don’t forget to check back for the latest updates to the PCSK9 Forum educational slide resource programme


Like us on Facebook
For the latest updates, PCSK9 news and analysis.
Follow us on Twitter
Hot topics, news and conference reports.
YouTube Channel
For videos, interviews and webcasts from leading experts.
Educational Partners
and Supporters
Amgen The Medicines Company Sanofi
Copyright PCSK9 Forum 2019. Please click here to unsubscribe from future mailings.